References
- Dasari S, Theis JD, Vrana JA, et al. Amyloid typing by mass spectrometry in clinical practice: a comprehensive review of 16,175 samples. Mayo Clin Proc. 2020 Sep;95(9):1852–1864. doi: 10.1016/j.mayocp.2020.06.029.
- Canetti D, Nocerino P, Rendell NB, et al. Clinical ApoA-IV amyloid is associated with fibrillogenic signal sequence. J Pathol. 2021 Nov;255(3):311–318. doi: 10.1002/path.5770.
- Muchtar E, Dispenzieri A, Magen H, et al. Systemic amyloidosis from A (AA) to T (ATTR): a review. J Intern Med. 2021 Mar;289(3):268–292. doi: 10.1111/joim.13169.
- Sidiqi MH, McPhail ED, Theis JD, et al. Two types of amyloidosis presenting in a single patient: a case series. Blood Cancer J. 2019 Mar 5;9(3):30. doi: 10.1038/s41408-019-0193-9.
- Bergström J, Murphy CL, Weiss DT, et al. Two different types of amyloid deposits–apolipoprotein A-IV and transthyretin–in a patient with systemic amyloidosis. Lab Invest. 2004 Aug;84(8):981–988. doi: 10.1038/labinvest.3700124.